ATE401346T1 - Asthma-empfindlichkeitsort - Google Patents

Asthma-empfindlichkeitsort

Info

Publication number
ATE401346T1
ATE401346T1 AT03767837T AT03767837T ATE401346T1 AT E401346 T1 ATE401346 T1 AT E401346T1 AT 03767837 T AT03767837 T AT 03767837T AT 03767837 T AT03767837 T AT 03767837T AT E401346 T1 ATE401346 T1 AT E401346T1
Authority
AT
Austria
Prior art keywords
gpra
asthma
gene
locus
describes
Prior art date
Application number
AT03767837T
Other languages
English (en)
Inventor
Tarja Laitinen
Juha Kere
Lauri Laitinen
Anne Polvi
Siru Maekelae
Johanna Vendelin
Ville Pulkkinen
Paula Salmikangas
Original Assignee
Geneos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneos Oy filed Critical Geneos Oy
Application granted granted Critical
Publication of ATE401346T1 publication Critical patent/ATE401346T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03767837T 2002-12-20 2003-12-19 Asthma-empfindlichkeitsort ATE401346T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43584602P 2002-12-20 2002-12-20
US43789503P 2003-01-03 2003-01-03
US45876703P 2003-03-26 2003-03-26
US48600003P 2003-07-09 2003-07-09

Publications (1)

Publication Number Publication Date
ATE401346T1 true ATE401346T1 (de) 2008-08-15

Family

ID=32686287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767837T ATE401346T1 (de) 2002-12-20 2003-12-19 Asthma-empfindlichkeitsort

Country Status (6)

Country Link
US (1) US20080182236A1 (de)
EP (1) EP1572739B1 (de)
AT (1) ATE401346T1 (de)
AU (1) AU2003292273A1 (de)
DE (1) DE60322259D1 (de)
WO (1) WO2004056866A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005045038A2 (en) * 2003-10-23 2005-05-19 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF GPRA AND AAA1 GENE EXPRESSION USING SHORT NUCLEIC ACID (siNA)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151046A1 (en) * 2000-06-16 2002-10-17 Glucksmann Maria Alexandra 52871, a novel human G protein coupled receptor and uses thereof
EP1254220A1 (de) * 1999-09-08 2002-11-06 Lexicon Genetics Incorporated Menschliche g protein-gekoppelten 7 transmembran-rezeptor und diese kodierende polynukleotide
EP1242454A2 (de) * 1999-12-28 2002-09-25 PHARMACIA & UPJOHN COMPANY G-proteingekoppelte rezeptoren
WO2001048188A1 (fr) * 1999-12-28 2001-07-05 Helix Research Institute Nouveaux recepteurs couples a la proteine de liaison a guanosine triphosphate, leurs genes, leur preparation et leur utilisation
JP2001245666A (ja) * 2000-03-06 2001-09-11 Kyowa Hakko Kogyo Co Ltd 新規ポリペプチド
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
AU2001229503A1 (en) * 2000-08-28 2002-03-13 Human Genome Sciences, Inc. 17 human secreted proteins
EP1329508B1 (de) * 2000-10-13 2010-09-08 Takeda Pharmaceutical Company Limited Neues g-protein-gekoppeltes rezeptorprotein und seine dna
US20030027252A1 (en) * 2000-11-22 2003-02-06 Tularik, Inc. Novel receptors
JP2005503111A (ja) * 2001-02-07 2005-02-03 インサイト・ゲノミックス・インコーポレイテッド Gタンパク質共役受容体
WO2003007187A1 (fr) * 2001-07-12 2003-01-23 Takeda Chemical Industries, Ltd. Procede d'evaluation de ligand et utilisation de ce procede
US7323541B2 (en) * 2001-09-14 2008-01-29 Takeda Pharmaceutical Company Limited Polypeptide DNA thereof and use of the same
EP1365030A1 (de) * 2002-05-21 2003-11-26 MTM Laboratories AG G Protein-gekoppelte Rezeptoren als Marker für colorectale Läsionen

Also Published As

Publication number Publication date
EP1572739B1 (de) 2008-07-16
WO2004056866A8 (en) 2005-07-21
AU2003292273A1 (en) 2004-07-14
EP1572739A1 (de) 2005-09-14
DE60322259D1 (de) 2008-08-28
US20080182236A1 (en) 2008-07-31
WO2004056866A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
UA90082C2 (ru) Выделенное моноклональное антитело человека, которое специфически связывается с cd25 человека и ингибирует связывание il-2 с cd25
ATE482722T1 (de) Therapeutische verwendung von anti-cs1- antikörpern
LU93274I2 (fr) Elotuzumab
WO2008105797A3 (en) Polynucleotides encoding novel pcsk9 variants
WO2003029421A3 (en) Regulated breast cancer genes
MX2008009886A (es) Anticuerpos que enlazan par-2.
SG156625A1 (en) Method for measuring resistance or sensitivity to docetaxel
WO2003105773A3 (en) Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
BR0312483A (pt) Anticorpos e seus usos
DE60322259D1 (de) Asthma-empfindlichkeitsort
EP1496743A4 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
WO2003083046A3 (en) Novel proteins and nucleic acids encoding same
WO2005017102A3 (en) Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
WO2001064876A3 (en) Human schizophrenia gene
WO2007143578A3 (en) Perforin-2 proteins
DE602004017439D1 (de) Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten
WO2004005540A3 (de) Verwendungen von an ngal bindenden substanzen zur diagnose und behandlung von krebserkrankungen
WO2006108051A3 (en) Compositions and methods relating to alzheimer's disease
WO2003102159A3 (en) Novel proteins and nucleic acids encoding same
WO2006029838A3 (en) Secreted polypeptide species involved in alzheimer’s disease
WO2002064788A3 (en) Compositions and methods relating to lung specific genes and proteins
WO2003020911A3 (en) Human schizophrenia gene
DK1644493T3 (da) Regulering af en kinase, 'reguleret i COPD kinase' (RC-kinase)
DE60222669D1 (de) Asthma-assoziiertes gen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties